Friday, April 5, 2019

FDA warns of potential violations at 21 stem cell clinics, manufacturers

BioPharma Dive-14 hours ago
The Food and Drug Administration chastised the stem cell industry for not doing enough ... artificial intelligence-based medical devices and compounded drugs.
Gottlieb Pushes Full Steam Ahead at the FDA
BioSpace (press release) (blog)-16 hours ago

No comments: